Eisenmenger syndrome
ORPHA:97214Malformation syndromeNot applicableAdolescent, Adult, Childhood
Фенотипы (HPO)58
Очень частый (80–99%)3
HP:0001627Abnormal heart morphology
HP:0002092Pulmonary arterial hypertension
HP:0003546Exercise intolerance
Частый (30–79%)10
HP:0001324Muscle weakness
HP:0001962Palpitations
HP:0002875Exertional dyspnea
HP:0004755Supraventricular tachycardia
HP:0005110Atrial fibrillation
HP:0005115Supraventricular arrhythmia
HP:0005317Increased pulmonary vascular resistance
HP:0012378Fatigue
HP:0012418Hypoxemia
HP:0030148Heart murmur
Периодический (5–29%)31
HP:0000961Cyanosis
HP:0001217Clubbing
HP:0001254Lethargy
HP:0001392Abnormality of the liver
HP:0001541Ascites
HP:0001609Hoarse voice
HP:0001629Ventricular septal defect
HP:0001631Atrial septal defect
HP:0001643Patent ductus arteriosus
HP:0001681Angina pectoris
HP:0001694Right-to-left shunt
HP:0001708Right ventricular failure
HP:0001891Iron deficiency anemia
HP:0002098Respiratory distress
HP:0002105Hemoptysis
HP:0002240Hepatomegaly
HP:0003270Abdominal distention
HP:0004756Ventricular tachycardia
HP:0004840Hypochromic microcytic anemia
HP:0005180Tricuspid regurgitation
HP:0006695Atrioventricular canal defect
HP:0010741Pedal edema
HP:0011227Elevated circulating C-reactive protein concentration
HP:0011604Aortopulmonary window
HP:0011712Right bundle branch block
HP:0012382Left-to-right shunt
HP:0012398Peripheral edema
HP:0030848Elevated jugular venous pressure
HP:0030849Hepatojugular reflux
HP:0031138Abnormal B-type natriuretic peptide level
HP:0100749Chest pain
Очень редкий (1–4%)14
HP:0000083Renal insufficiency
HP:0001279Syncope
HP:0001297Stroke
HP:0001636Tetralogy of Fallot
HP:0001892Abnormal bleeding
HP:0002149Hyperuricemia
HP:0002321Vertigo
HP:0004308Ventricular arrhythmia
HP:0005518Increased mean corpuscular volume
HP:0006689Bacterial endocarditis
HP:0007430Generalized edema
HP:0030049Brain abscess
HP:0030828Wheezing
HP:0100724Hypercoagulability
Эпидемиология2
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | 1-9 / 1 000 000 | 0.2 | Belgium | Value and class |
| Point prevalence | 1-9 / 1 000 000 | — | Europe | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)